Dechra Pharmaceuticals posts rise in quarterly revenues

Dechra Pharmaceuticals reported an increase in revenue in the first three months of the year as a rise in Europe sales offset a fall in the US.

Dechra Pharmaceuticals reported an increase in revenue in the first three months of the year as a rise in Europe sales offset a fall in the US.

Group revenue for its third quarter was up 14.6% ahead of last year, according to a trading update Wednesday.

For the nine months ended March 31st, group revenue increased 18.4% compared to the previous year.

A 69.8% jump in quarterly revenues in the European Pharmaceuticals segment drove results. The division climbed 69.7% in the nine-month period.

The acquisition of Eurovet Animal Health last May boosted revenues.

Companion animal products for the nine months to the end of March grew by 11.0% on a like-for-like basis.

Farm animal products, which continued to be affected by a focus on the reduction of antibiotics in Europe, rose by 1.0%. Pet diet jumped 2.0%.

In the US, revenue declined 14.4% in the quarter and were broadly flat in the nine month period, reflecting supply problems from a third party manufacturer. Customer back orders exceeded $1.0m.

Services segment revenues dropped 2.5% in the quarter, due to a weak performance in the UK veterinary market. Poor weather resulted in significantly reduced footfall through veterinary practices.

Revenue for the nine months was, however, was 2.7% ahead of the previous year.

"The strong performance reported in the first half of thefinancial year has been partly offset by a weaker than expected third quarter which was affected by poor weather in Northern Europe and third party supply problems within the US," the company said.

The company said it does not anticipate that the third quarter's performance will materially impact its expectations for the full year as trading picked up in April.

Shares fell 2.25% to 696p at 09:40 Wednesday.

RD

Recommended

Why it pays to face up to your investment mistakes
Investment strategy

Why it pays to face up to your investment mistakes

Buying stocks can be a complicated business. But selling stocks can be tricky, too – even if you sell for the right reasons. Max King explains how to …
17 Sep 2021
Share tips of the week – 17 September
Share tips

Share tips of the week – 17 September

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
17 Sep 2021
Royal Mail will deliver for investors – here's how to play it
Trading

Royal Mail will deliver for investors – here's how to play it

Royal Mail Group has found its feet in the past 18 months and looks cheap. Matthew Partridge looks at how to trade the shares.
14 Sep 2021
The times may be changing, but don’t change how you invest
Small cap stocks

The times may be changing, but don’t change how you invest

We are living in strange times. But the basics of investing remain the same: buy fairly-priced stocks that can provide an income. And there are few be…
13 Sep 2021

Most Popular

The times may be changing, but don’t change how you invest
Small cap stocks

The times may be changing, but don’t change how you invest

We are living in strange times. But the basics of investing remain the same: buy fairly-priced stocks that can provide an income. And there are few be…
13 Sep 2021
Two shipping funds to buy for steady income
Investment trusts

Two shipping funds to buy for steady income

Returns from owning ships are volatile, but these two investment trusts are trying to make the sector less risky.
7 Sep 2021
Should investors be worried about stagflation?
US Economy

Should investors be worried about stagflation?

The latest US employment data has raised the ugly spectre of “stagflation” – weak growth and high inflation. John Stepek looks at what’s going on and …
6 Sep 2021